Your browser doesn't support javascript.
loading
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.
Chevalier, Thomas; Daste, Amaury; Saada-Bouzid, Esmaa; Loundou, Anderson; Peyraud, Florent; Lambert, Tiphaine; Le Tourneau, Christophe; Peyrade, Frédéric; Dupuis, Charlotte; Alfonsi, Marc; Fayette, Jérôme; Reure, Juliette; Huguet, Florence; Fakhry, Nicolas; Toullec, Clémence; Salas, Sébastien.
Afiliação
  • Chevalier T; Department of Medical Oncology, CHU la Timone, AP-HM, Marseille, France.
  • Daste A; Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital-CHU, Bordeaux, France.
  • Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Loundou A; EA3279, Self-Perceived Health Assessment Research Unit, Aix-Marseille University, Marseille, France.
  • Peyraud F; Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital-CHU, Bordeaux, France.
  • Lambert T; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Institut Curie, Paris & Saint-Cloud, France.
  • Le Tourneau C; Department of Drug Development and Innovation (D3i), Paris-Saclay University, Institut Curie, Paris & Saint-Cloud, France.
  • Peyrade F; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Dupuis C; Department of Medical Oncology, CHU la Timone, AP-HM, Marseille, France.
  • Alfonsi M; Department of Radiation Oncology, Clinique Sainte Catherine, Avignon, France.
  • Fayette J; Department of Medical Oncology, Léon Bérard Center, University of Lyon, Lyon, France.
  • Reure J; Department of Medical Oncology, Léon Bérard Center, University of Lyon, Lyon, France.
  • Huguet F; Department of Radiation Oncology, Tenon Hospital, Paris Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Fakhry N; Department of Otorhinolaryngology - Head and Neck Surgery, AP-HM, Aix-Marseille University, France.
  • Toullec C; Department of Medical Oncology, Clinique Sainte Catherine, Avignon, France.
  • Salas S; Department of Medical Oncology, CHU la Timone, AP-HM, Marseille, France.
Cancer Med ; 10(12): 3952-3963, 2021 06.
Article em En | MEDLINE | ID: mdl-34080776
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Cetuximab / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Cetuximab / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França